Physiology chages during pregnancy
| Parameter | Change |
|---|---|
| Neurological - MAC | -40% |
| Oxygen consumption | +20 to 50% |
| Minute ventilation | +50% |
| Tidal volume | +40% |
| FRC | -20% |
| Airway resistance | -35% |
| PaCO2 | -15% |
| HCO3- | -15% |
| Blood volume | +35% |
| Plasma volume | +55% |
| Cardiac output | +40% |
| Stroke volume | +30% |
| Heart rate | +20% |
| Systolic BP | -5% |
| Diastolic BP | -15% |
| Peripheral resistance | -15% |
| Hemoglobin | -20% |
| Clotting factors | +30 to 250% |
| GFR | +50% |

| Hormone | Effect |
|---|---|
| Progesterone | Sedation, reduced MAC, LES relaxation, smooth muscle relaxation |
| Estrogen | Fluid retention, mucous membrane engorgement (difficult airway) |
| hCG | Nausea/vomiting (peak at 8-12 weeks) |
| hPL | Insulin resistance, lipid mobilization |
Detail
| Sign | Description | Cause |
|---|---|---|
| Linea nigra | Dark line from pubis to above umbilicus | Increased MSH (melanocyte-stimulating hormone) |
| Chloasma/melasma gravidarum | Mask of pregnancy - hyperpigmentation of face | Estrogen + MSH effect |
| Striae gravidarum | Stretch marks on abdomen, breasts, thighs | Skin stretching + glucocorticoid effect on dermal collagen |
| Palmar erythema | Redness of the palms | Elevated estrogen levels |
| Spider angiomas/telangiectasiae | Vascular spiders on skin | Elevated estrogen |
| Vulval hyperpigmentation | Darkening of external genitalia | Elevated MSH + estrogen |
| Increased sweating | Hyperhidrosis | Increased basal metabolic rate |
| Nail changes | Soft, brittle nails with transverse grooves | Metabolic changes |
| Component | Weight |
|---|---|
| Fetus | ~3.3 kg |
| Placenta | ~0.6 kg |
| Amniotic fluid | ~0.8 kg |
| Uterus (hypertrophy) | ~0.9 kg |
| Breast tissue | ~0.4 kg |
| Blood volume increase | ~1.2 kg |
| Extracellular/extravascular fluid | ~1.2 kg |
| Maternal fat stores | ~3.5 kg |
| Factor | Change |
|---|---|
| Fibrinogen (Factor I) | Increases 50-100% (from ~300 → 450-600 mg/dL) |
| Factor VII | Increases |
| Factor VIII | Increases |
| Factor IX | Increases |
| Factor X | Increases |
| Factor XII (Hageman) | Increases |
| Factor XI | May decrease |
| Protein S | Decreases (anticoagulant) |
| Protein C | Unchanged |
| Antithrombin III | Slightly decreased |
| Fibrinolysis | Accelerated late in third trimester |
| Parameter | Change | Notes |
|---|---|---|
| Tidal Volume (TV) | +40% | Most significant change |
| Respiratory Rate | +15% | Mild increase |
| Minute Ventilation | +50% | TV × RR |
| Inspiratory Reserve Volume | Slight increase | |
| Functional Residual Capacity (FRC) | -20% | Returns to normal in 48h post-delivery |
| Expiratory Reserve Volume | Decreases | Primary cause of FRC reduction |
| Vital Capacity | Minimally affected | |
| Closing Capacity | Minimally affected | |
| Physiological Dead Space | Decreases | Narrows arterial-end tidal CO2 gradient |
| Airway Resistance | -35% | Progesterone-mediated bronchial smooth muscle relaxation |
| Parameter | Change |
|---|---|
| PaO2 | Slightly increased (+10%) |
| PaCO2 | Decreases to 28-32 mmHg (-15%) |
| HCO3- | Decreases to ~18-22 mEq/L (-15%) - compensatory |
| pH | Slightly alkalotic (7.40-7.45) |
| P50 (hemoglobin) | Increases from 27 → 30 mmHg (rightward shift) |
| Compound | Non-Gravid | Late Pregnancy |
|---|---|---|
| Glucose | 79 mg/dL | 68 mg/dL (↓) |
| Insulin | 9.8 μU/mL | 16.2 μU/mL (↑) |
| Amino acids | 3.82 μmol/L | 3.18 μmol/L (↓) |
| Free fatty acids | 76 mg/dL | 181 mg/dL (↑) |
| Cholesterol | 163 mg/dL | 205 mg/dL (↑) |
| Hormone | Source | Key Physiological Effect |
|---|---|---|
| Progesterone | Corpus luteum → placenta | Smooth muscle relaxation (uterus, GI, vessels, bronchi), sedation, ↑ ventilation, ↓ LES tone |
| Estrogen | Corpus luteum → placenta | Ductal growth, fluid retention, skin changes, ↑ TBG, ↑ coagulation factors |
| hCG | Trophoblasts | Maintains corpus luteum; nausea/vomiting (hCG peak = morning sickness peak at 9 weeks) |
| hCS/hPL | Placenta | Insulin resistance, lipolysis, ensures fetal glucose supply |
| Placental GH | Placenta | Insulin resistance |
| Relaxin | Corpus luteum, decidua | Joint laxity, cervical softening, inhibits contractions |
| Prolactin | Anterior pituitary | Breast lobular development, lactogenesis (inhibited by E2 + P4 during pregnancy) |
| MSH | Anterior pituitary | Skin pigmentation (linea nigra, chloasma) |